Biochemistry · 1998 · 48 citations · 38 references
MedicineMolecular BiologyOncologyGene ExpressionOncogenesTranscriptional RegulationMyc Family OncogenesOncogene ActivationOncogenic ProliferationTranscription Factor OncogenesTranscription In EukaryotesBiomolecular Binding AffinityMyc OncogenesMyc Proto-oncogenePhosphodiester OligonucleotidesPhosphorothioate ModificationPromotersReporter Gene AssaysTriplex-forming Oligonucleotides
Triplex-forming oligonucleotides (TFOs) have been shown to inhibit both transcription in vitro and the expression of target genes in cell culture by binding to polypurine/polypyrimidine sequences in several human gene promoters. The c-myc protooncogene is overexpressed in a variety of human cancers and appears to play an important role in the proliferation of these cells. In an attempt to assay the ability of triplex-forming oligonucleotides to inhibit expression of a target gene in vivo, we have developed a cellular system involving transfection of a c-myc promoter-driven luciferase reporter plasmid with triplex-forming oligonucleotides targeted to the human c-myc protooncogene. To increase the stability of the TFO, we have used modified phosphorothioate oligonucleotides. Triplex formation with a modified phosphorothioate oligonucleotide occurs with approximately equal binding affinity as that seen using a phosphodiester oligonucleotide. Phosphorothioate-modified TFOs targeted to c-myc inhibit transcription of the c-myc promoter in HeLa cells as demonstrated by a decrease in luciferase expression from a luciferase reporter gene construct. These results suggests that triplex formation may represent a gene-specific means of inhibiting specific protooncogene expression.
38
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Michael E. Greenberg, Edward B. Ziff · Nature · 1984 · 3.2K citations
Jim Battey, Christopher Moulding, Rebecca Taub et al. · Cell · 1983 · 736 citations · Full text